Trials / Conditions / Microscopic Polyangiitis (MPA)

Microscopic Polyangiitis (MPA)

10 registered clinical trials studyying Microscopic Polyangiitis (MPA) — 5 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Comparison of a Strategy Based on Clinico-biological Monitoring Versus Pre-emptive Rituximab Treatment in Case NCT07451847	Assistance Publique - Hôpitaux de Paris	Phase 4
Recruiting	Safe Effective Therapy With Low-Dose Glucocorticoid in ANCA-Associated Vasculitis (SAFE-LOW) NCT06983821	Ottawa Hospital Research Institute	Phase 3
Recruiting	Special Drug Use-results Survey for Long-term Use（Avacopan） NCT06758271	Kissei Pharmaceutical Co., Ltd.	—
Unknown	Efficacy and Safety of Rituximab in the Treatment of Good Prognosis Microscopic Polyangiitis NCT03920722	Assistance Publique - Hôpitaux de Paris	Phase 3
Completed	Study of IFX-1 to Replace Steroids in Patients With Granulomatosis With Polyangiitis and Microscopic Polyangii NCT03895801	InflaRx GmbH	Phase 2
Terminated	Safety and Efficacy Study of IFX-1 in add-on to Standard of Care in GPA and MPA NCT03712345	InflaRx GmbH	Phase 2
Recruiting	Clinical Transcriptomics in Systemic Vasculitis (CUTIS) NCT03004326	Peter Merkel	—
Recruiting	Vasculitis Pregnancy Registry NCT02593565	University of Pennsylvania	—
Completed	The ANCA Vasculitis Questionnaire (AAV-PRO©) NCT02507024	University of Pennsylvania	—
Completed	Plasma Exchange and Glucocorticoids for Treatment of Anti-Neutrophil Cytoplasm Antibody (ANCA) - Associated Va NCT00987389	University of Pennsylvania	Phase 3